bound coordination [19] . This mode of binding is observed exclusively at four-coordinate platinum(II) and palladium(II) centres [20] [21] [22] [23] [24] [25] [26] [27] . Most pertinent to the work described herein are pyridine (py) and substituted pyridine adducts, cis-[Pt(sac) 2 (py) 2 ], prepared upon addition of sodium saccharinate to the relevant dichlorides [20] . This behavior is different to that noted for [PtCl 2 ( 2 -dppf)] [dppf = bis(diphenylphosphino)ferrocene], which even under forcing conditions adds only a single equivalent of saccharinate to afford [PtCl(sac)( 2 -dppf)] [27] . Given the importance of both cisplatin and saccharin we were surprised to find that the interaction of the two had not to be noted in the literature. Herein we report that saccharinate readily displaces both chlorides of cisplatin to afford cis-[Pt(sac) 2 (NH 3 ) 2 ] (1) which has been crystallographically characterized and give preliminary details of its anti-cancer activity together with that of the related thiosaccharinate (tsac) complex, cis-[Pt(tsac) 2 (NH 3 ) 2 ] (2), which we postulate contains a PtN 2 S 2 core.
Cis-[Pt(sac) 2 (NH 3 ) 2 ] (1) was obtained as colorless crystals upon treatment of cisplatin with two equivalents of sodium saccharinate in boiling water 1 . It is soluble in dimethylformamide (DMF) and DMSO, but insoluble in other common organic solvents. For comparison the related thiosaccharinate (tsac) complex cis-[Pt(tsac) 2 (NH 3 ) 2 ] (2) was prepared 2 (Scheme 1). It shows far greater solubility in common organic solvents, believed to be a result of the binding of this ligand through sulfur [19, 27] . The facile formation of 2 is somewhat surprising as 1 reactions of cisplatin with thiols generally result in loss of ammonia rather [28] [29] [30] [31] .
Formation of 1-2 probably results from direct attack of the saccharinate or thiosaccharinate anions on cisplatin [32, 33] since it is known that aquation of cisplatin is slow [13] [14] [15] [16] [17] [18] .
A crystallographic study of 1 (which crystallizes with a molecule of water) was carried out 3
( Figure 1 ). The Pt-N1 and Pt-N2 bond distances 2.042(4) and 2.018(4) Å are similar to other Pt(II)-saccharinate complexes [19] [20] [21] [22] [23] [24] [25] [26] [27] . The Pt-N3 and Pt-N4 distances of 2.044 (4) protons appear as a singlet at  4.54. In the absence of a crystallographic study we cannot unequivocally deduce the regioselectivity but strongly favour a relative cis arrangement of ligands.
We have undertaken preliminary anti-cancer activity studies [42] on both complexes against A549 human alveolar type-II cell lines 4 and using methotrexate as a positive control and an MTT assay was used to determine their dose-dependent cytotoxicity 5 after 24 and 48 h ( Figure 2 ). These show that 2 has higher activity than 1 and the activity of the former at higher concentrations (100 g/ml and 250 g/ml) is significantly greater than the control at these concentrations. Reasons for this are not clear, but it is well-known that a significant amount of cisplatin is hydrolysed outside of the cell and renally excreted upon binding to plasma proteins, and thus only ca. 10% binds to DNA. It may be that the strong Pt-S bond results in more of the complex penetrating into the cell and becoming DNA bound. An alternative explanation is that the trans labilization of thiolates leads to a quite different mechanism of action in which ammine loss may be significant [28] [29] [30] [31] . It is somewhat surprising that cis-[Pt(SR) 2 (NH 3 ) 2 ] complexes remain elusive given the strength of the Pt-S interaction. Indeed sulfur-coordinating ligands are potential "rescue agents" or "protecting agents" providing competition with methionine and cysteine residues in proteins to reduce adverse binding thereby diminishing toxic side effects [29] . With this in mind we are currently further exploring the cytotoxicity of 2 together with that of related Pt(II)thiosaccharinate complexes. 
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